DIA-NN was created in 2017 at the University of Cambridge, to make large-scale proteomics a reality.
DIA-NN serves as the basis for multiple DIA technologies, such as plexDIA, Slice-PASEF and QuantUMS.
We keep advancing LC-MS proteomics as a reliable and streamlined technology that ensures quantitative accuracy.
Key highlights for DIA-NN in 2025
Aptila is delighted to announce a collaboration & reseller agreement with Thermo Fisher Scientific
Indivumed and Aptila announce collaboration utilizing Aptila’s proteomics expertise
In proteomics, can we direct all peptide ions to fragmentation, therefore maximising sensitivity?
A new version with key improvements towards accurate proteomics
